ITEMS IN AFP WITH KEYWORD:
The U.S. Department of Veterans Affairs and U.S. Department of Defense (VA/DoD) published updated guidelines for the treatment of headache disorders based on a systematic review.
Achieving cure from medication overuse headaches after six months was likely regardless of strategy: detoxification (discontinuation of analgesic) plus pharmacologic prophylaxis, pharmacologic prophylaxis without withdrawal, or detoxification with pharmacologic preventive therapy delayed for two months.
Lasmiditan is a costly alternative to other more extensively studied medications for acute migraine. It should be reserved for those patients who lack relief with other available agents or who cannot tolerate other abortive medications.
May 1, 2020 Issue
Migraines in Children: Recommendations for Acute and Preventive Treatment [Practice Guidelines]
Updated recommendations for the prevention and treatment of migraines in children and adolescents were recently published by the American Academy of Neurology and the American Headache Society, and they are based on a systematic review of new evidence published between January 2003 and August 2017.
In otherwise healthy adults with severe and frequent migraine or cluster headaches, galcanezumab may provide a modest reduction in debilitating headache frequency in the short term.
Repeated headaches can induce central sensitization and transformation to chronic headaches that are intractable and difficult to treat. Learn which red flag features to watch for that could signal serious underlying pathology.
Feb 1, 2020 Issue
OnabotulinumtoxinA for Prevention of Migraine in Adults [Cochrane for Clinicians]
OnabotulinumtoxinA reduces the number of migraine days per month by two days compared with placebo in adults with chronic migraines.
Erenumab is a safe option for migraine prophylaxis in adults. However, it is expensive and should be reserved for patients who have experienced intolerable adverse effects while taking oral migraine prophylaxis medication or who have poor adherence to daily preventive treatment.
Mar 1, 2019 Issue
Hemorrhoids, Tremor, C. difficile Infection, Migraine, Vitamin D Screening [AFP Clinical Answers]
Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.
Preventive therapy has been shown to be beneficial to many patients with episodic migraines. Indications for therapy include four or more headaches or eight or more headache days a month, debilitating headaches, and medication-overuse headaches. First- and second-line medications are available for treatment; managing environmental, dietary, and behaviorial triggers is useful in preventive therapy. Nonpharmacologic prevention options are also discussed.